Dr. Azra Raza, MD

Dr. Raza practices at Columbia University Irving Medical Center in New York, New York.

Dr. Raza's NPI, 1104809656, was assigned on November 29, 2005. Dr. Raza graduated from Dow University of Health Sciences in 1975. Dr. Raza holds New York license 146813.

Dr. Raza's primary practice is Columbia University Irving Medical Center, at 622 W 168th St, New York, NY 10032 in New York County. The practice phone is (212) 297-4255.

Dr. Raza's primary practice is Columbia University Irving Medical Center in New York, New York. Dr. Raza is also affiliated with NewYork-Presbyterian/Weill Cornell Medical Center. The medical group on file is ColumbiaDoctors. Dmand AI also links Dr. Raza to 2 more group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Raza practices, 3 sites in all. Vendor and product names are available with a free account.

Medical oncology is Dr. Raza's primary specialty in the NPI Registry, under taxonomy code 207RX0202X. Dr. Raza is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Raza's licenses on file in 4 states: New York, Massachusetts, Illinois and Ohio.

Dmand AI lists chronic anemia and chronic leukemia among the conditions Dr. Raza treats.

CMS data shows 298 Medicare services from Dr. Raza across 4 procedure codes in 2024, for 69 Medicare patients. Medicare paid $38,402 for them. Every service was in an office.

CMS counts 69 Medicare patients who saw Dr. Raza in 2024. The largest group is 75 to 84, with 33 patients. 75% of them have high cholesterol, and 72% have high blood pressure. Their average risk score is 2.68, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Raza's median patient age at 76, with 38% women.

In 2024, Dr. Raza wrote 13 Medicare Part D claims.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Raza for performance year 2024, reported through an alternative payment model (APM). Dr. Raza accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Raza as offering telehealth.

Dmand AI links 159 papers to Dr. Raza, published from 2006 to 2025. 2016 was the busiest year, with 5. The most frequent topics are Myelodysplastic Syndromes, Bone Marrow and Leukemia, Myeloid, Acute. Dr. Raza has published most often in Leuk Res. Dr. Raza's most frequent co-authors are Stephanie Gregory, MD, Sefer Gezer, MD and Richard A. Larson.

Dmand AI links Dr. Raza to 3 clinical trials. Conditions studied include Myelodysplastic Syndromes, Bone Marrow Diseases and Anemia, Refractory. Traws Pharma, Inc. sponsors the most, 2.

CMS Open Payments shows 310 general payments to Dr. Raza from 13 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 61% of the total. Novartis Pharmaceuticals Corporation paid the most, $374,914.

Dmand AI lists 2 awards for Dr. Raza, most recently Top Doctors: New York Metro Area in 2014.

Dr. Raza graduated from Dow University of Health Sciences in 1975.

Dr. Raza is in network with 13 carriers, including Aetna, Excellus BlueCross BlueShield and Elevance. PPO plans come from the most carriers, 8. Check the plan with the practice before a visit.